Research: Mycoplasma genitalium antimicrobial resistance surveillance (MARS)
Surveillance of antimicrobial resistance in Mycoplasma genitalium (M. genitalium) in England is conducted through the M. genitalium Antimicrobial Resistance Surveillance (MARS) Programme. MARS sentinel surveillance data is obtained annually from a network of sexual health services and their associated laboratories. The programme aims to:
Surveillance of antimicrobial resistance is critical in guiding national management guidelines to ensure appropriate treatments. Continued surveillance of antimicrobial resistance in M. genitalium through MARS will provide a rich resource for informing future updates to management guidelines in the UK.
Pilot collections for this programme were conducted in 2019 and 2020. Previous MARS reports are available from the UK Government Web Archive.
Cases of treatment failure to second-line therapeutics, such as moxifloxacin, should be reported to UK Health Security Agency using the HIV and STI Data Exchange
This is an extract. The publication continues at the source.
Read the original at the source: https://www.gov.uk/government/publications/mycoplasma-genitalium-antimicrobial-resistance-surveillance-mars
Officially imported this from UK Health Security Agency’s own source and shows an extract. If you work there, claiming the profile and verifying the domain lets you choose to show the full text here.
Provenance
- Organization
- UK Health Security Agency — imported from official source
- Official source
- https://www.gov.uk/government/organisations/uk-health-security-agency.atom ATOM
- Imported
- September 21, 2026 09:30
- Versions
- 1 recorded
- Identity
https://www.gov.uk/government/publications/mycoplasma-genitalium-antimicrobial-resistan...